GLAXOSMITHKLINE PHARMA LT (GLAXO)

NSE: ₹2,166.60
BSE: ₹2,166.50
Stock Performance
Corporate Announcements
2026-06-08 11:42:04
AGM Notice For 2025-26

As per attachment

2026-06-05 19:49:40
2026-06-05 19:48:19
Reg. 34 (1) Annual Report.

Annual Report for 2025-26

2026-06-05 19:45:09
Announcement under Regulation 30 (LODR)-Change in Management

Resignation of Dr. Simrat Sohal as Compliance officer of the Company

2026-05-29 12:38:56
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Compliance Secretarial Report for year ended March 2026

2026-05-26 10:24:56

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 738.02 953.38 804.98 910.87 811.00 1,000.05 946.36 966.08 804.83 973.63 1,022.59 989.15
YOY Revenue Growth % 1.17% 5.27% 0.73% 16.46% 9.89% 4.9% 17.56% 6.06% -0.76% -2.64% 8.06% 2.39%
Other Income 36.80 28.47 28.34 29.87 35.85 32.19 35.06 39.46 43.76 31.27 31.82 35.71
Total Income 774.82 981.85 833.32 940.74 846.85 1,032.24 981.42 1,005.54 848.59 1,004.90 1,054.41 1,024.86
Total Expenses + 613.41 685.34 604.90 674.43 598.36 698.23 675.07 650.64 570.02 656.89 676.52 655.74
Cost of Materials Consumed 145.47 79.71 87.52 192.29 133.33 137.25 91.93 108.35 121.43 107.07 70.10 101.47
Employee Benefit Expense 165.00 145.21 141.35 172.83 151.28 150.71 124.74 152.97 152.57 138.05 151.88 164.75
Other Expenses 156.48 171.55 132.15 133.60 137.49 153.78 180.00 136.03 113.54 150.36 154.05 140.79
Operating Profit 124.61 268.04 200.08 236.44 212.64 301.82 271.29 315.44 234.81 316.74 346.07 333.41
OPM % 16.9% 28.1% 24.9% 26% 26.2% 30.2% 28.7% 32.7% 29.2% 32.5% 33.8% 33.7%
Profit Before Tax + 178.71 296.51 65.11 268.71 248.49 338.70 306.35 354.90 278.57 350.65 377.89 369.12
Tax Expense 48.13 80.97 19.62 75.63 66.84 90.01 77.77 94.76 73.87 95.65 100.71 94.18
Tax % 26.9% 27.3% 30.1% 28.1% 26.9% 26.6% 25.4% 26.7% 26.5% 27.3% 26.7% 25.5%
Profit After Tax 130.58 215.54 45.49 193.08 181.65 248.69 228.58 260.14 204.70 255.00 277.18 274.94
EPS (Basic) 6.94 12.72 9.88 11.39 10.72 14.45 13.49 15.35 12.08 14.92 16.36 16.23

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 3,790.20 3,723.49 3,407.25 3,216.34 3,217.51 3,193.73 3,224.68
YOY Revenue Growth % 1.79% 9.28% 5.94% -0.04% 0.74% -0.96% -
Other Income 142.56 142.56 123.48 101.52 76.22 110.19 77.56
Total Income 3,932.76 3,866.05 3,530.73 3,317.86 3,293.73 3,303.92 3,302.24
Total Expenses + 2,559.17 2,622.30 2,578.08 2,484.51 2,531.86 2,581.59 1,732.74
Cost of Materials Consumed 400.07 470.86 504.99 394.35 552.47 452.64 474.38
Employee Benefit Expense 607.25 579.70 624.39 594.99 610.23 614.69 628.55
Other Expenses 558.74 607.30 593.78 571.91 555.71 578.87 629.81
Operating Profit 1,231.03 1,101.19 829.17 731.83 685.65 612.14 1,491.94
OPM % 32.5% 29.6% 24.3% 22.8% 21.3% 19.2% 46.3%
Profit Before Exceptional 1,373.59 1,243.75 952.65 833.35 761.87 722.33 646.99
Exceptional Items 2.64 4.69 -143.61 -0.97 11.58 -172.60 -324.49
Profit Before Tax + 1,376.23 1,248.44 809.04 832.38 773.45 549.73 322.50
Tax Expense 364.41 329.38 224.35 224.63 -917.08 192.17 212.45
Tax % 26.5% 26.4% 27.7% 27% -118.6% 35% 65.9%
Profit After Tax 1,011.82 919.06 584.69 607.75 1,690.53 357.56 110.05
EPS (Basic) 59.00 54.01 34.51 35.88 99.79 21.11 6.50

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 553.26 524.57 573.49 652.51 759.01 582.93 0.00
Property, Plant & Equipment 273.51 269.54 296.80 294.81 294.94 340.91 0.00
Capital Work in Progress 32.92 14.32 13.93 20.31 30.50 13.21 0.00
Non-Current Investments 25.36 24.49 24.49 24.49 24.49 24.49 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 6.56 13.33 23.55 34.09 34.50 43.36 0.00
Current Assets + 3,721.65 3,576.36 2,974.31 2,675.19 3,863.48 2,332.74 0.00
Inventories 430.35 463.17 514.30 437.70 512.71 523.34 0.00
Trade Receivables 273.11 292.55 222.06 192.38 205.24 215.60 0.00
Cash and Cash Equivalents 1,065.82 536.22 62.15 29.74 280.79 404.90 0.00
Current Investments 1,000.00 1,000.00 813.22 518.29 365.59 0.00 0.00
LIABILITIES & EQUITY
Total Equity 2,241.18 1,949.23 1,784.09 1,753.00 2,677.62 1,517.94 0.00
Equity Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 0.00
Other Equity 2,071.77 1,779.82 1,614.68 1,583.59 2,508.21 1,348.53 0.00
Non-Current Liabilities 276.63 250.89 252.76 257.68 270.62 280.54 0.00
Current Liabilities 1,757.10 1,900.81 1,510.95 1,317.02 1,674.36 1,297.31 0.00
Total Liabilities 2,033.73 2,151.70 1,763.71 1,574.70 1,944.98 1,577.85 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 881.42 1,280.03 578.93 487.94 819.80 594.86 0.00
Cash from Investing Activities 385.25 -36.54 14.97 805.19 -419.66 408.14 0.00
Cash from Financing Activities -737.07 -769.42 -561.49 -1,544.18 -524.25 -696.13 0.00
Net Increase/Decrease in Cash 529.60 474.07 32.41 -251.05 -124.11 306.87 0.00